Accedi

Jodie Hay

Paul O'Gorman Leukaemia Research Centre,
Institute of Cancer Sciences,
College of Medical,
Veterinary and Life Sciences,
Paul O'Gorman Leukaemia Research Centre, Institute of Cancer Sciences, College of Medical, Veterinary and Life Sciences

University of Glasgow

BIOGRAPHY

Jodie Hay is a Research Associate at the Paul O'Gorman Leukaemia Research Centre part of the University of Glasgow. She received her undergraduate with honours degree in Forensic Science with Chemistry from The Robert Gordon University, Aberdeen, and a Ph.D. in Medicine from the Queen's University Belfast.

During Dr Hay's training she has worked on a number of haematological malignancies including AML, T-ALL and B cell lymphoma. She joined the Michie group in 2018 as a senior postdoctoral research scientist to explore the cellular and molecular mechanisms that underlie the initiation and progression of chronic lymphocytic leukaemia (CLL), with a view to identifying novel targets for therapeutic intervention.

PUBLICATIONS

Addiction to Runx1 is partially attenuated by loss of p53 in the Eµ-Myc lymphoma model.

Oncotarget Apr, 2016 | Pubmed ID: 27056890

The RUNX Genes as Conditional Oncogenes: Insights from Retroviral Targeting and Mouse Models.

Advances in experimental medicine and biology , 2017 | Pubmed ID: 28299662

RUNX oncoproteins and miRNA networks.

Oncotarget Sep, 2017 | Pubmed ID: 28968950

Integrated analysis of the molecular action of Vorinostat identifies epi-sensitised targets for combination therapy.

Oncotarget Sep, 2017 | Pubmed ID: 28978082

RUNX-mediated growth arrest and senescence are attenuated by diverse mechanisms in cells expressing RUNX1 fusion oncoproteins.

Journal of cellular biochemistry 03, 2018 | Pubmed ID: 29052866

AKT/mTORC2 Inhibition Activates FOXO1 Function in CLL Cells Reducing B-Cell Receptor-Mediated Survival.

Clinical cancer research : an official journal of the American Association for Cancer Research Mar, 2019 | Pubmed ID: 30559170

Collaboration of MYC and RUNX2 in lymphoma simulates T-cell receptor signaling and attenuates p53 pathway activity.

Journal of cellular biochemistry Oct, 2019 | Pubmed ID: 31257681

INSTITUTIONS

University of Glasgow

JOVE ARTICLES

Subcellular Fractionation of Primary Chronic Lymphocytic Leukemia Cells to Monitor Nuclear/Cytoplasmic Protein Trafficking

Jodie Hay^*,1,

Michael W. Moles^*,1,

Jennifer Cassels¹,

Alison M. Michie¹

¹Paul O'Gorman Leukaemia Research Centre, Institute of Cancer Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow

JoVE Journal

Riservatezza

Condizioni di utilizzo

Politiche

Contattaci

SUGGERISCI JOVE ALLA BIBLIOTECA

Newsletter di JoVE

Ricerca

JoVE Journal
Raccolta di metodi
JoVE Encyclopedia of Experiments
Archivio

Didattica

JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Sportello unico per docenti
Faculty Site

Autori

Panoramica
Processo di pubblicazione
Comitato editoriale
Ambito e politiche
Revisione paritaria
Domande frequenti
Invia

Personale delle biblioteche

Panoramica
Testimonianze
Abbonamenti
Accesso
Risorse
Comitato consultivo della biblioteca
Domande frequenti

CHI SIAMO

Panoramica
Direzione
Blog